These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22437861)

  • 21. [Pharmaceutical care in primary health care: the experience of 3 Brazilian States].
    Cosendey MA; Bermudez JA; Reis AL; Silva HF; Oliveira MA; Luiza VL
    Cad Saude Publica; 2000; 16(1):171-82. PubMed ID: 10738162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential medicines and technology incorporation following novel Brazilian Public Health System regulations.
    Santos-Pinto Cdu B; Ventura M; Pepe VL; Osorio-de-Castro CG
    Cad Saude Publica; 2013 Jun; 29(6):1056-8. PubMed ID: 23778537
    [No Abstract]   [Full Text] [Related]  

  • 23. Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.
    Bird RC
    J Law Med Ethics; 2009; 37(2):209-21. PubMed ID: 19493067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basic survival needs and access to medicines--coming to grips with TRIPS: conversion + calculation.
    Van Puymbroeck RV
    J Law Med Ethics; 2010; 38(3):520-49. PubMed ID: 20880239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How the Uruguayan Judiciary Shapes Access to High-Priced Medicines: A Critique through the Right to Health Lens.
    Pizzarossa LB; Perehudoff K; Forte JC
    Health Hum Rights; 2018 Jun; 20(1):93-105. PubMed ID: 30008555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patently necessary: improving global access to essential medicines.
    CMAJ; 2003 Dec; 169(12):1257, 1259. PubMed ID: 14662658
    [No Abstract]   [Full Text] [Related]  

  • 27. The silent victims of the US embargo against Iran.
    Ghalibafian M; Hemmati S; Bouffet E
    Lancet Oncol; 2018 Nov; 19(11):e580. PubMed ID: 30507483
    [No Abstract]   [Full Text] [Related]  

  • 28. Access to Medicines in Times of Conflict: Overlapping Compliance and Accountability Frameworks for Syria.
    Leyh BM; Gispen ME
    Health Hum Rights; 2018 Jun; 20(1):237-250. PubMed ID: 30008566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of pharmacy interventions in improving availability of essential medicines at the primary healthcare level.
    Nunan M; Duke T
    Trop Med Int Health; 2011 May; 16(5):647-58. PubMed ID: 21342375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Falsified medicines in Africa.
    Ziemer T
    Lancet Glob Health; 2015 Feb; 3(2):e82. PubMed ID: 25617200
    [No Abstract]   [Full Text] [Related]  

  • 31. Accelerating access to medicines in a changing world.
    Kettler H; Lehtimaki S; Schwalbe N
    Bull World Health Organ; 2020 Sep; 98(9):641-643. PubMed ID: 33012865
    [No Abstract]   [Full Text] [Related]  

  • 32. Applying human rights to improve access to reproductive health services.
    Shaw D; Cook RJ
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S55-9. PubMed ID: 22883913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lawsuits to antineoplastic drugs: the tip of an iceberg?
    Vidal TJ; Moraes EL; Retto MPF; Silva MJSD
    Cien Saude Colet; 2017 Aug; 22(8):2539-2548. PubMed ID: 28793070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the pharmaceutical industry improving with regard to access to essential medicines?
    Hogerzeil HV; Iyer JK; Urlings L; Prasad T; Brewer S
    Lancet Glob Health; 2014 Mar; 2(3):e139-40. PubMed ID: 25102843
    [No Abstract]   [Full Text] [Related]  

  • 35. Not just a tragedy: access to medications as a right under international law.
    Yamin AE
    Boston Univ Int Law J; 2003; 21(2):325-71. PubMed ID: 16514750
    [No Abstract]   [Full Text] [Related]  

  • 36. Medicines prices and Malaysia--untangling the medicines web.
    Hill S
    PLoS Med; 2007 Mar; 4(3):e149. PubMed ID: 17388686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Access to medicines and global health: will Canada lead or flounder?
    Orbinski J
    CMAJ; 2004 Jan; 170(2):224-6. PubMed ID: 14734437
    [No Abstract]   [Full Text] [Related]  

  • 38. A new Lancet Commission on Essential Medicines.
    Lancet; 2014 Nov; 384(9955):1642. PubMed ID: 25441180
    [No Abstract]   [Full Text] [Related]  

  • 39. Ensuring patient access to essential medicines while minimizing harmful use: a revised World Health Organization tool to improve national drug control policy.
    Gilson AM; Maurer MA; Ryan KM; Skemp-Brown M; Husain A; Cleary JF
    J Pain Palliat Care Pharmacother; 2011; 25(3):246-51. PubMed ID: 21882978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential medicines twenty-five years on: closing the access gap.
    Quick JD
    Health Policy Plan; 2003 Mar; 18(1):1-3. PubMed ID: 12582103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.